244 related articles for article (PubMed ID: 36641977)
1. Efficacy of Lianhua Qingwen for children with SARS-CoV-2 Omicron infection: A propensity score-matched retrospective cohort study.
Xu X; Wu H; Jin G; Huang J; Li J; Zhou J; Cao M; Sun D; Zhang W; Peng W; Pu Y; Chen C; Sun Y; Yang H; Zhou S; Fang B
Phytomedicine; 2023 Mar; 111():154665. PubMed ID: 36641977
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Huashi Baidu Granules in Treating Patients with SARS-CoV-2 Omicron Variant: A Single-Center Retrospective Cohort Study.
Chen CY; Zhang W; Xu XR; Pu YT; Tu YD; Peng W; Yao X; Zhou S; Fang BJ
Chin J Integr Med; 2024 Feb; 30(2):107-114. PubMed ID: 37222827
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and Safety of Lianhua Qingwen Capsules for COVID-19: A Propensity-Score Matched Cohort Study.
Lu Y; Zhang M; Yang QQ; Li WJ; Yang K; Hu W; Gao SY; Jiang QL; Lin LK; Cheng H; Sun F
Evid Based Complement Alternat Med; 2023; 2023():6028554. PubMed ID: 36846053
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of Reyanning mixture in patients infected with SARS-CoV-2 Omicron variant: A prospective, open-label, randomized controlled trial.
Xu X; Zhou S; Chen C; Li J; Wu H; Jin G; Zhou J; Wang G; Cao M; Sun D; Zhang W; Peng W; Pu Y; Sun Y; Fang B; Xu J
Phytomedicine; 2023 Jan; 108():154514. PubMed ID: 36334390
[TBL] [Abstract][Full Text] [Related]
5. Effect of Lianhua Qingwen capsules on the positive rate of COVID-19 close contacts: A retrospective analysis of a large-scale population-based cohort study.
Qiao Y; Xu X; Zhou F; Wang K; Li M; Liu C; Chen Z; Yin P; Shi Y; Wang Y; Liu Q
Phytomedicine; 2023 Apr; 112():154690. PubMed ID: 36780823
[TBL] [Abstract][Full Text] [Related]
6. Impact of Lianhua Qingwen on viral shedding in omicron mild/asymtomatic patients: a real-world study.
Gai X; Yan C; Wu C; Duan Z; Fan J; Yuan S; Yang P; Bao F; Jing H; Cai C; Ma Y; Zhang W; Sun Y
Front Med (Lausanne); 2024; 11():1357299. PubMed ID: 38596791
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of Lianhua Qingwen capsules combined with standard of care in the treatment of adult patients with mild to moderate COVID-19 (FLOSAN): protocol for a randomized, double-blind, international multicenter clinical trial.
Zhan YQ; Chen RF; Zheng QS; Li XW; Liu YN; Mootsikapun P; Chayakulkeeree M; Arttawejkul P; Lan TTN; Liu GG; Lu HZ; Liu QQ; Zhong NS; Yang ZF; Zheng JP
J Thorac Dis; 2023 May; 15(5):2859-2872. PubMed ID: 37324081
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics of children with Omicron variant infection in Chengdu area, China].
Jiang J; Yang M; Li DY; Qiao LN; Zhang HY
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Aug; 25(8):849-854. PubMed ID: 37668034
[TBL] [Abstract][Full Text] [Related]
9. Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects.
Li LC; Zhang ZH; Zhou WC; Chen J; Jin HQ; Fang HM; Chen Q; Jin YC; Qu J; Kan LD
Biomed Pharmacother; 2020 Oct; 130():110641. PubMed ID: 34321172
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics and related factors of viral nucleic acid negative conversion in children infected with Omicron variant strain of SARS-CoV-2].
Yin R; Lu Q; Jiao JL; Lin K; Wang C; Yuan L; Ding Y; Dong N; Wang BJ; Niu YH; Fang YS; Liu W; Sun YF; Zou B; Zhang XE; Xiao P; Sun L; Du X; Zhu YY; Dong XY
Zhonghua Er Ke Za Zhi; 2022 Dec; 60(12):1307-1311. PubMed ID: 36444435
[No Abstract] [Full Text] [Related]
11. [Clinical features of children and their family members with family clusters of SARS-CoV-2 Omicron variant infection in Shanghai, China: an analysis of 380 cases].
Bian XL; Guo Z; Zhang K; Li MC; Wu ZM; Jiang Q; Guo MM; Fan SN; Chen JJ; Hui L; Zheng F; Zhang JP
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Oct; 24(10):1085-1091. PubMed ID: 36305107
[TBL] [Abstract][Full Text] [Related]
12. Effect of Nasal Irrigation in Children With Omicron Variant of COVID-19 Infection.
Liu L; Wang C; Xie S; Su L; Wang C
Ear Nose Throat J; 2024 Jun; 103(1_suppl):54S-59S. PubMed ID: 37329222
[No Abstract] [Full Text] [Related]
13. Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19.
Hong L; He M; Li S; Zhao J
Chin Med; 2022 Jul; 17(1):84. PubMed ID: 35799189
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of clinical characteristics and prognosis of 4 264 patients with asymptomatic and mild novel coronavirus infections in Shanghai].
Xu X; Sun D; Cao M; Zhang W; Pu Y; Chen C; Sun Y; Zhou S; Fang B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 May; 34(5):449-453. PubMed ID: 35728842
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant.
Liu X; Chen M; Zhou Z; Chen D; Mo J; Liu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):344-351. PubMed ID: 35545327
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019.
Wang DC; Yu M; Xie WX; Huang LY; Wei J; Lei YH
J Integr Med; 2022 Jan; 20(1):26-33. PubMed ID: 34782291
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Huashi Baidu granule plus Nirmatrelvir-Ritonavir combination therapy in patients with high-risk factors infected with Omicron (B.1.1.529): A multi-arm single-center, open-label, randomized controlled trial.
Yu Z; Zheng Y; Chen B; Lv J; Zhu X; Shang B; Xv Y; Tao R; Yang Y; Cong J; Li D; Wu H; Qv W; Zhang X; Xv C; Feng H; Yuan W; Gao Y
Phytomedicine; 2023 Nov; 120():155025. PubMed ID: 37639813
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features of severe acute respiratory syndrome coronavirus 2 Omicron variant infection in children: an analysis of 201 cases].
Zhang YF; Liang SS; Wu PL; Cai YL; Lin YL; Wang QW; Zhuang XB; Chen SQ
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jan; 25(1):5-10. PubMed ID: 36655657
[TBL] [Abstract][Full Text] [Related]
19. Characterization of mild or asymptomatic patient admitted with Omicron variant of COVID-19 infection in Tibetan mobile cabin hospital China, August-October 2022.
Shao F; Li B; Shang JJ; Liu WB; Wang HB; Liu QQ
Front Public Health; 2023; 11():1174944. PubMed ID: 37621611
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of awake prone positioning treatment in patients with common coronavirus disease 2019 caused by Omicron variant].
Wang Z; Feng Q; Yu H; Shi L; Xu L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jun; 34(6):576-580. PubMed ID: 35924510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
